The chip maker—which counts Apple, Samsung Electronics and Tesla among its customers—expects lower sales, as demand for legacy semiconductors remains subdued.
The pharmaceutical giant said for 2025 it anticipates sales growth in the mid-single-digit range at constant exchange rates, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback